Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation

Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation

Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial fibrillation (AF) over 75 years old.Material and methods. The observation study included patients ≥75 years of age with confirmed AF, receiving dabigatran in a reduced dosage, apixaban or rivaroxaban in full...

Full description

Bibliographic Details
Main Authors: M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2020-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
atrial fibrillation
non-vitamin k oral anticoagulants
elderly
bleeding
dabigatran
rivaroxaban
apixaban
Online Access:https://www.rpcardio.com/jour/article/view/2071

Internet

https://www.rpcardio.com/jour/article/view/2071

Similar Items